28012257
2017 Aug
The long-term clinical impact of low-level viremia (LLV; Conclusion:LLV observed during entecavir monotherapy was associated with a higher risk of HCC, especially for those with cirrhosis, indicating that LLV during potent antiviral therapy is consequential. (Hepatology 2017;66:335-343).

